drug · small molecule
patient view →naltrexone ER
Marketedupdated 2mo agoby $AARD Aardvark Therapeutics, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 47 investigational indications.
targets
Opioid receptors; mu/kappa/delta
all catalysts(28)
approval · 28
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that